... drugs -- including single selling agents and combination drugs -- have been approved by the FDA for treatment of HIV/AIDS. Despite patent expirations of early HIV drugs in mid 2000s, the industry continued to innovate and was able to come up with ...
http://www.fool.com/investing/general/2013/08/27/can-this-hiv-drug-challenge-gileads-domination.aspx
http://www.fool.com/investing/general/2013/08/27/can-this-hiv-drug-challenge-gileads-domination.aspx
No comments:
Post a Comment